Figure 1. GID SVF-1 device (Louisville, CO) with concentrated cell pellet. From: Adipose Derived Stromal Cell (ADSC) Injections for Pain Management of Osteoarthritis in the Human Knee Joint Aesthet Surg J. 2015;36(2):229-236. doi:10.1093/asj/sjv135 Aesthet Surg J | © 2015 The American Society for Aesthetic Plastic Surgery, Inc. Reprints and permission: journals.permissions@oup.com
Figure 2. Preoperative, 3-month postoperative, and 1-year postoperative WOMAC Scores. From: Adipose Derived Stromal Cell (ADSC) Injections for Pain Management of Osteoarthritis in the Human Knee Joint Aesthet Surg J. 2015;36(2):229-236. doi:10.1093/asj/sjv135 Aesthet Surg J | © 2015 The American Society for Aesthetic Plastic Surgery, Inc. Reprints and permission: journals.permissions@oup.com
Figure 3. Preoperative, 3-month postoperative, and 1-year postoperative VAS Scores. From: Adipose Derived Stromal Cell (ADSC) Injections for Pain Management of Osteoarthritis in the Human Knee Joint Aesthet Surg J. 2015;36(2):229-236. doi:10.1093/asj/sjv135 Aesthet Surg J | © 2015 The American Society for Aesthetic Plastic Surgery, Inc. Reprints and permission: journals.permissions@oup.com